used switchable CAR-T cells targeting HER2 in a patient-derived xenograft model of stage IV advanced pancreatic ductal adenocarcinoma (PDAC) to simulate the significant liver and lung metastases seen at this stage. Here, ERBB2 is linked to pancreatic ductal adenocarcinoma.